Cooper Simon Peter
Insider CIK 1877225 · KROS Chief Medical Officer · MORF CMO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MORF Morphic Holding, Inc. | D To issuer deriv | 2024-08-16 | 2024-08-20 | 7,000 | — | $0 | 0 | SEC↗ |
| MORF Morphic Holding, Inc. | D To issuer deriv | 2024-08-16 | 2024-08-20 | 14,000 | — | $0 | 0 | SEC↗ |
| MORF Morphic Holding, Inc. | D To issuer deriv | 2024-08-16 | 2024-08-20 | 170,000 | — | $0 | 0 | SEC↗ |
| MORF Morphic Holding, Inc. | A Award deriv | 2024-03-18 | 2024-03-19 | 14,000 | — | $0 | 14,000 | SEC↗ |
| MORF Morphic Holding, Inc. | A Award deriv | 2024-03-18 | 2024-03-19 | 7,000 | — | $0 | 7,000 | SEC↗ |
| MORF Morphic Holding, Inc. | A Award deriv | 2024-03-18 | 2024-03-19 | 170,000 | — | $0 | 170,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2024-02-13 | 2024-02-15 | 40,000 | — | $0 | 40,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2023-02-16 | 2023-02-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2022-01-21 | 2022-01-25 | 50,000 | — | $0 | 50,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2021-08-10 | 2021-08-11 | 60,000 | — | $0 | 60,000 | SEC↗ |